| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8381805eba6d034fc77bd230dd02e6e2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 |
| filingDate |
2008-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be64c77e857da81f871ddf9fc4195c6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35adc2c343faee78fc3f54a10d5fdc24 |
| publicationDate |
2009-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2009042906-A1 |
| titleOfInvention |
Methods for treating cancers associated with constitutive egfr signaling |
| abstract |
Aspects of the invention relate to methods and compositions for treating cancers associated with constitutive EGFR signaling. Methods include inhibiting one or more components of the c-Met and/or Axl signaling pathways. Aspects of the invention also relate to methods for determining whether a subject is a candidate for treatment with an inhibitor of a c-Met and/or Axl signaling component. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011014872-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9580508-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9593164-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012159655-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9168300-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11702475-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011014872-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10954284-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9695228-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9695242-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10662235-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10196446-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10240207-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9725497-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11072663-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11628222-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11781138-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11447539-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014081954-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11299534-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11345739-B2 |
| priorityDate |
2007-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |